Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $101,595 | 24 | 95.4% |
| Food and Beverage | $4,209 | 71 | 4.0% |
| Honoraria | $495.68 | 4 | 0.5% |
| Gift | $175.63 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $101,595 | 24 | $0 (2023) |
| Johnson & Johnson Surgical Vision, Inc. | $490.60 | 7 | $0 (2021) |
| NotalVision | $452.02 | 4 | $0 (2017) |
| ABBVIE INC. | $423.93 | 7 | $0 (2024) |
| Genentech USA, Inc. | $359.98 | 14 | $0 (2024) |
| Allergan Inc. | $332.15 | 3 | $0 (2019) |
| TissueTech, Inc. | $327.20 | 3 | $0 (2020) |
| Heidelberg Engineering, Inc. | $299.62 | 2 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $274.81 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $219.84 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $477.30 | 17 | Tarsus Pharmaceuticals, Inc. ($125.00) |
| 2023 | $54,968 | 22 | Baxter Healthcare ($54,660) |
| 2022 | $47,105 | 16 | Baxter Healthcare ($46,935) |
| 2021 | $453.66 | 5 | Johnson & Johnson Surgical Vision, Inc. ($234.44) |
| 2020 | $274.56 | 2 | Carl Zeiss Meditec, Inc. ($175.63) |
| 2019 | $1,360 | 17 | Novartis Pharmaceuticals Corporation ($274.81) |
| 2018 | $382.86 | 5 | Allergan Inc. ($125.46) |
| 2017 | $1,455 | 16 | NotalVision ($452.02) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Ophthalmology | ||||||
| 09/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Ophthalmology | ||||||
| 07/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: Ophthalmology | ||||||
| 06/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: EYE CARE | ||||||
| 05/21/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/08/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Ophthalmology | ||||||
| 04/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/22/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 02/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Ophthalmology | ||||||
| 12/08/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $3,035.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 11/15/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $3,110.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 10/25/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $16.15 | General |
| 10/13/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $4,765.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 09/20/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/08/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $4,890.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/11/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $4,610.00 | General |
| Category: Physical Assessment, Vision | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,693 | 15,282 | $8.8M | $2.7M |
| 2022 | 17 | 3,630 | 9,867 | $7.0M | $2.3M |
| 2021 | 21 | 3,583 | 9,714 | $7.0M | $2.5M |
| 2020 | 19 | 3,160 | 8,584 | $6.2M | $2.2M |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 266 | 2,520 | $5.0M | $1.7M | 34.4% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 86 | 1,133 | $1.1M | $239,212 | 21.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 420 | 1,555 | $855,250 | $143,445 | 16.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 21 | 4,740 | $398,160 | $137,752 | 34.6% |
| 92134 | Imaging of retina | Office | 2023 | 856 | 2,101 | $262,625 | $59,315 | 22.6% |
| J3490 | Unclassified drugs | Office | 2023 | 18 | 32 | $145,090 | $52,143 | 35.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 30 | 312 | $257,700 | $51,782 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 478 | 803 | $160,600 | $49,413 | 30.8% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 15 | 270 | $90,720 | $32,497 | 35.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 321 | 332 | $87,980 | $28,604 | 32.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 243 | 260 | $70,200 | $27,230 | 38.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 24 | 26 | $60,060 | $23,291 | 38.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 180 | 180 | $56,700 | $19,468 | 34.3% |
| 92250 | Photography of the retina | Office | 2023 | 346 | 526 | $49,970 | $14,333 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 131 | $35,370 | $11,596 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $33,950 | $11,313 | 33.3% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $26,455 | $10,247 | 38.7% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 12 | 13 | $23,660 | $8,203 | 34.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 58 | 142 | $21,300 | $7,508 | 35.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 54 | 55 | $10,450 | $3,349 | 32.0% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 15 | 16 | $12,000 | $2,959 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $4,070 | $1,431 | 35.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 11 | 16 | $2,400 | $574.99 | 24.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 239 | 2,436 | $4.9M | $1.8M | 36.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 40 | 717 | $586,200 | $159,746 | 27.3% |
About Dr. Ryan Young, MD
Dr. Ryan Young, MD is a Ophthalmology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1902127947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Young, MD has received a total of $106,475 in payments from pharmaceutical and medical device companies, with $477.30 received in 2024. These payments were reported across 100 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($101,595).
As a Medicare-enrolled provider, Young has provided services to 14,066 Medicare beneficiaries, totaling 43,447 services with total Medicare billing of $9.6M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Austin, TX
- Active Since 06/14/2010
- Last Updated 05/04/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1902127947
Products in Payments
- Hillrom - RetinaVue 700 Imager (Device) $101,595
- OZURDEX (Drug) $488.29
- ForeseeHome (Device) $452.02
- Prokera (Device) $327.20
- Spectralis (Device) $299.62
- Vabysmo (Drug) $262.19
- Humira (Biological) $211.14
- CLARUS (Device) $175.63
- RetinaVue Network (Device) $150.00
- EVA Ophthalmic Surgical System (Device) $141.73
- Lucentis (Biological) $137.22
- ACTHAR (Biological) $135.25
- Tecnis Multifocal Family of 1-piece IOLS (Device) $128.10
- Avenova (Device) $125.00
- Tecnis Simplicity (Device) $121.95
- XIIDRA (Drug) $121.85
- EYLEA (Biological) $121.65
- BEOVU (Drug) $115.71
- EYLEA AFLIBERCEPT INJECTION (Biological) $113.74
- One Series Ultra (Device) $112.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Austin
Vikram Durairaj, Md, MD
Ophthalmology — Payments: $516,103
Dr. Sheila Barbarino, M.d, M.D
Ophthalmology — Payments: $236,894
Dr. Thomas Walters, Md, MD
Ophthalmology — Payments: $217,539
Chirag Jhaveri, M.d, M.D
Ophthalmology — Payments: $211,408
Dr. Steven Dell, M.d, M.D
Ophthalmology — Payments: $177,840
Dr. Aaron Roller, M.d, M.D
Ophthalmology — Payments: $154,063